Targeted ablation of Par-4 reveals a cell type-specific susceptibility to apoptosis-inducing agents

El Bachir Affar1, Margaret Po-shan Luke, Frédérique Gay

  • 1Department of Pathology, Harvard Medical School, 77 Louis Pasteur Avenue, Boston, MA 02115, USA.

Cancer Research
|April 6, 2006
PubMed

Insights

Prostate apoptosis response-4 (Par-4) protein

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Prostate apoptosis response-4 (Par-4) is implicated in cell death and tumorigenesis.
  • The COOH-terminal domain of Par-4 is suggested to be crucial for apoptosis mediation.

Purpose of the Study:

  • To investigate the in vivo biological role of the COOH-terminal domain of Par-4.
  • To determine the necessity of Par-4 for apoptosis induction in different cellular contexts.

Main Methods:

  • Generation of knock-out mice lacking the COOH terminus of Par-4.
  • Treatment of primary fibroblasts from mutant and wild-type mice with apoptotic stimuli.
  • RNA interference (RNAi)-mediated knockdown of Par-4 in mouse fibroblasts and HeLa cells.

Main Results:

  • Par-4 mutant mice are viable and fertile, showing no developmental defects.
  • Par-4 deficient fibroblasts exhibit normal sensitivity to apoptosis-inducing agents.
  • Par-4 depletion in HeLa cells significantly inhibits apoptosis induced by proapoptotic agents.

Conclusions:

  • The proapoptotic function of Par-4 is context-dependent.
  • The COOH-terminal domain is not essential for Par-4's role in embryogenesis or developmental apoptosis.
  • Altered Par-4 function may be involved in carcinogenesis.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.